The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota

Neurogastroenterology and Motility

Volumn 25, Issue 4, 2013, Pages

  Crouzet, L ^a   Gaultier, E ^a   Del'Homme, C ^a   Cartier, C ^a   Delmas, E ^a   Dapoigny, M ^b   Fioramonti, J ^a   Bernalier Donadille, A ^a  

^a CEMAGREF   (France)

^b University Estaing   (France)

Author keywords

Colonic mucosa; Colorectal sensitivity; Gnotobiotic rats; Gut microbiota; Irritable bowel syndrome

Indexed keywords

ABDOMINAL PAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIACEAE; CASE REPORT; CELL MEMBRANE PERMEABILITY; COLON DILATATION; COLON MUCOSA; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; ENTEROBACTERIACEAE; EPITHELIAL PARACELLULAR PERMEABILITY; EPITHELIUM CELL; FECES ANALYSIS; FECES CULTURE; FECES MICROFLORA; FEMALE; GERMFREE ANIMAL; GNOTOBIOTICS; HUMAN; HYPERSENSITIVITY; IRRITABLE COLON; MALE; MAST CELL; MICROBIAL COLONIZATION; MOLECULAR DIAGNOSIS; NONHUMAN; PATIENT COMPLIANCE; PATIENT TRANSPORT; PRIORITY JOURNAL; RAT; VISCERAL HYPERSENSITIVITY;

ADULT; ANIMALS; COLON; FECES; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; HYPERSENSITIVITY; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MICROBIOTA; MIDDLE AGED; RATS; RATS, INBRED F344; SPECIES SPECIFICITY;

EID: 84875627943     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12103     Document Type: Article

References (55)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
2. Whitehead WE, Holtkotter B, Enck P et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990; 98: 1187-92.
3. Azpiroz F, Bouin M, Camilleri M et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007; 19(Suppl. 1): 62-88.
4. Salonen A, De Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2012; 156: 3205-15.
5. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 317: 779-82.
6. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 412-9.
7. Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1231-8.
8. Roka R, Rosztoczy A, Leveque M et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007; 5: 550-5.
9. Jeffery IB, O'Toole PW, Öhman L et al. An irritable bowel syndrome subtype defined by species-species alterations in faecam microbiota. Gut 2011; 61: 997-1006.
10. Kassinen A, Krogius-kurikka L, Makivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
11. Kerckhoffs AP, Samsom M, van der Rest ME et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009; 15: 2887-92.
12. Malinen E, Rinttila T, Kajander K et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-82.
13. Matto J, Maunuksela L, Kajander K et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 213-22.
14. Rajilic-Stojanovic M, Biagi E, Heilig HGHJ et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1792-801.
15. Chassard C, Dapoigny M, Scott KP et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 2012; 35: 828-38.
16. Mortensen PB, Andersen JR, Arffmann S, Krag E. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol 1987; 22: 185-92.
17. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22: 512-9.
18. Treem WR, Ahsan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996; 23: 280-6.
19. De Filippo C, Cavalieri D, Di Paola M et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-6.
20. Verdu EF, Bercik P, Verma-Gandhu M et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006; 55: 182-90.
21. Ait-Belgnaoui A, Han W, Lamine F et al. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 2006; 55: 1090-4.
22. Rousseaux C, Thuru X, Gelot A et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13: 35-7.
23. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.
24. Houghton LA, Fell C, Whorwell PJ, Jones I, Sudworth DP, Gale JD. Effect of second-generation a2 g ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 2007; 56: 1218-25.
25. Clarke KR, Owens JP. A simple and versatile microcomputer for determination of Most Probable Number. J Microbiol Methods 1983; 1: 133-7.
26. Hungate RE. A roll tube method for the cultivation of strict anaerobes. In: Norris JR, Ribbons DW, eds. Methods in Microbiology, vol 3B. London and New York: Academic Press, 1969: 117-32.
27. Furet JP, Firmesse O, Gourmelon M et al. Comparative assessment of human and farm animal fecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 2009; 68: 351-62.
28. Lay C, Doré J, Rigottier-Rois L. Separation of bacteria of the Clostridium leptum subgroup from the human colonic microbiota by fluorescent-activated cell sorting or group-specific PCR using 16S rRNA gene oligonucleotides. FEMS Microbiol Ecol 2007; 60: 513-20.
29. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009; 101: 541-50.
30. Le Coz Y, Morel MT, Bousseboua H, Dufour C, Szylit O. Development of a respiratory chamber and its connexion with an isolator: a method to measure the in vivo production of fermentation gas by gnotobiotic animals. Sci Tech Anim Lab 1989; 14: 35-9.
31. Matulova M, Nouaille R, Capek P, Péan M, Forano E, Delort AM. Degradation of wheat straw by Fibrobacter succinogenes S85: a liquid and solid NMR study. Appl Environ Microbiol 2005; 71: 1247-53.
32. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-9.
33. Fabia R, Ar'Rajab A, Johansson ML et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993; 54: 248-55.
34. Alpert C, Sczesny S, Gruhl B, Blaut M. Long-term stability of the human gut microbiota in two different rat strains. Curr issues Mol Biol 2008; 10: 17-24.
35. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10: 1802-5.
36. Van der Veek PP, Steenvoorden M, Steens J, van der Schaar PJ, Brussee J, Masclee AA. Recto-colonic reflex is impaired in patients with irritable bowel syndrome. Neurogastroenterol Motil 2007; 19: 653-9.
37. Notivol R, Coffin B, Azpiroz F, Mearin F, Serra J, Malagelada JR. Gastric tone determines the sensitivity of the stomach to distention. Gastroenterology 1995; 108: 330-6.
38. Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain 2005; 113: 141-7.
39. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 2009; 146: 41-6.
40. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 1590-5.
41. Klooker TK, Braak B, Koopman KE et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010; 59: 1213-21.
42. Braak BB, Klooker TK, Wouters MM et al. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Am J Gastroenterol 2012; 107: 715-26.
43. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-101.
44. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
45. Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut 2008; 57: 582-90.
46. Abrams GD, Bauer H, Sprinz H. Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice. Lab Invest 1963; 12: 355-64.
47. Gordon HA, Bruckner-Kardoss E. Effect of the normal microbial flora on various tissue elements of the small intestine. Acta Anat (Basel) 1961; 44: 210-25.
48. Fukushima K, Sasaki I, Ogawa H, Naito H, Funayama Y, Matsuno S. Colonization of microflora in mice: mucosal defense against luminal bacteria. J Gastroenterol 1999; 34: 54-60.
49. Ishikawa K, Satoh Y, Tanaka H, Ono K. Influence of conventionalization on small-intestinal mucosa of germ-free Wistar rats: quantitative light microscopic observations. Acta Anat (Basel) 1986; 127: 296-302.
50. Enss ML, Wagner S, Liebler E, Coenen M, Hedrich HJ. Response of the germfree rat colonic mucosa to dietary endotoxins. J Exp Anim Sci 1996; 38: 58-65.
51. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-9.
52. Bourdu S, Dapoigny M, Chapuy E et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 2005; 128: 1996-2008.
53. Vanhoutvin SA, Troost FJ, Kilkens TO et al. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil 2009; 21: 952-8.
54. Koide A, Yamaguchi T, Odaka T et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1735-41.
55. Matsunami M, Tarui T, Mitani K et al. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 2009; 58: 751-61.